StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck varivax — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)

Form 10-Q / 10-K MD&A Pediatric Vaccines Disclosure

QuarterlyAnnual
Latest, Q2 2026
8.0%
Period ended Jun 30, 2026
Change on a year earlier
+18.0 pts
-10.0% in Q2 2025
History
20 quarters
Since Q1 2020
Sources
20
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVarivax — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)Year on yearSource
Q2 2026Jun 30, 20268.0%+18.0 ptsForm 10-Q (mrk-20260630.htm, filed 2026-08-07) ↗
Q1 2026Mar 31, 2026-7.0%-3.0 ptsForm 10-Q (mrk-20260331.htm, filed 2026-05-04) ↗
Q3 2025Sep 30, 2025-5.0%+2.0 ptsForm 10-Q (mrk-20250930.htm, filed 2025-11-05) ↗
Q2 2025Jun 30, 2025-10.0%-15.0 ptsForm 10-Q (mrk-20250630.htm, filed 2025-08-05) ↗
Q1 2025Mar 31, 2025-4.0%-15.0 ptsForm 10-Q (mrk-20250331.htm, filed 2025-05-02) ↗
Q3 2024Sep 30, 2024-7.0%-22.0 ptsForm 10-Q (mrk-20240930.htm, filed 2024-11-06) ↗
Q2 2024Jun 30, 20245.0%+7.0 ptsForm 10-Q (mrk-20240630.htm, filed 2024-08-05) ↗
Q1 2024Mar 31, 202411.0%-6.0 ptsForm 10-Q (mrk-20240331.htm, filed 2024-05-03) ↗
Q3 2023Sep 30, 202315.0%+17.0 ptsForm 10-Q (mrk-20230930.htm, filed 2023-11-03) ↗
Q2 2023Jun 30, 2023-2.0%-12.0 ptsForm 10-Q (mrk-20230630.htm, filed 2023-08-07) ↗
Q1 2023Mar 31, 202317.0%+16.0 ptsForm 10-Q (mrk-20230331.htm, filed 2023-05-05) ↗
Q3 2022Sep 30, 2022-2.0%-21.0 ptsForm 10-Q (mrk-20220930.htm, filed 2022-11-03) ↗
Q2 2022Jun 30, 202210.0%-27.0 ptsForm 10-Q (mrk-20220630.htm, filed 2022-08-05) ↗
Q1 2022Mar 31, 20221.0%-13.0 ptsForm 10-Q (mrk-20220331.htm, filed 2022-05-05) ↗
Q3 2021Sep 30, 202119.0%+28.0 ptsForm 10-Q (mrk-20210930.htm, filed 2021-11-05) ↗
Q2 2021Jun 30, 202137.0%+72.0 ptsForm 10-Q (mrk-20210630.htm, filed 2021-08-09) ↗

Cite this data

StockData. (2026). Merck Varivax — Worldwide constant-currency (ex-exchange) growth YoY (%) (%), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev_varivax_exfx_yoy

See every metric in the Merck KPI table. Data updated Oct 26, 2026.